Metagenomics in Healthcare Market size was valued at USD 1.5 Billion in 2024 and is projected to reach USD 5.9 Billion by 2033, exhibiting a CAGR of 16.8% from 2026 to 2033.
The global metagenomics market was valued at approximately USD 1.6 billion in 2022 and is projected to reach USD 4.6 billion by 2031, growing at a compound annual growth rate (CAGR) of 12.9% during the forecast period. North America dominated the market in 2023, accounting for a revenue share of 40.26%. This leadership is attributed to the presence of key companies, increased research and development funding, and advancements in sequencing technology. The United States, in particular, has been investing in R&D activities to enhance responsiveness to disease outbreaks. Europe follows closely, with countries like the United Kingdom, Germany, and France implementing national genomic initiatives and fostering collaborations to advance metagenomics research. For instance, the UKs Strategic Dialogue on Biological Security with the U.S. aims to promote responsible innovation in biotechnology and life sciences. The Asia Pacific region is experiencing the fastest growth in the metagenomics market, driven by substantial advancements in adoption across diverse applications in countries like China, Japan, and India. Chinas market is bolstered by prominent sequencing centers and government initiatives such as "Made in China 2025," aiming to strengthen the biotechnology sector. Japans market benefits from advanced technological capabilities and collaborations between industry leaders and academic institutions. In India, the metagenomics market generated a revenue of USD 69.4 million in 2023 and is expected to reach USD 172.8 million by 2030, growing at a CAGR of 13.9% from 2024 to 2030. Government initiatives like Digital India and Startup India are fostering innovation and investment in biotechnology, creating a conducive environment for metagenomics research and development. Overall, the global metagenomics market is poised for significant growth, with regional dynamics influenced by technological advancements, government support, and increasing applications in healthcare.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=569494&utm_source=Google_Site&utm_medium=226
Â
Illumina
QIAGEN
PerkinElmer
Thermo Fisher Scientific
Oxford Nanopore Technologies
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=569494&utm_source=Google_Site&utm_medium=226
Growing demand for below applications around the world has had a direct impact on the growth of the Global Metagenomics in Healthcare Market
Sequencing Platforms
Microbial Identification Kits
Bioinformatics Tools
Reagents and Consumables
Other Metagenomic Products
Infectious Disease Diagnosis
Oncology
Environmental Monitoring
Pharmacogenomics
Personalized Medicine
AmpliSeq
Shotgun Metagenomics
Targeted Amplicon Sequencing
16S rRNA Gene Sequencing
Metatranscriptomics
Hospitals and Clinics
Research Institutes
Diagnostic Laboratories
Pharmaceutical Companies
Academic Institutions
Clinical Research
Routine Diagnostics
Biopharmaceutical Development
Healthcare Quality Improvement
Public Health Surveillance
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/metagenomics-in-healthcare-market-size-and-forecast/
1. Introduction of the Global Metagenomics in Healthcare Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Metagenomics in Healthcare Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Metagenomics in Healthcare Market, By Type
6. Global Metagenomics in Healthcare Market, By Application
7. Global Metagenomics in Healthcare Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Metagenomics in Healthcare Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/